182 related articles for article (PubMed ID: 27247849)
41. Renal function and symptoms/adverse effects in opioid-treated patients with cancer.
Kurita GP; Lundström S; Sjøgren P; Ekholm O; Christrup L; Davies A; Kaasa S; Klepstad P; Dale O
Acta Anaesthesiol Scand; 2015 Sep; 59(8):1049-59. PubMed ID: 25943005
[TBL] [Abstract][Full Text] [Related]
42. Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study.
Puustinen J; Nurminen J; Löppönen M; Vahlberg T; Isoaho R; Räihä I; Kivelä SL
BMC Geriatr; 2011 Nov; 11():70. PubMed ID: 22044595
[TBL] [Abstract][Full Text] [Related]
43. Genetic Variants Associated with Cancer Pain and Response to Opioid Analgesics: Implications for Precision Pain Management.
Yang GS; Barnes NM; Lyon DE; Dorsey SG
Semin Oncol Nurs; 2019 Jun; 35(3):291-299. PubMed ID: 31085105
[TBL] [Abstract][Full Text] [Related]
44. Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.
Hooten WM; Hu D; Cunningham JM; Black JL
Mol Pain; 2019; 15():1744806919848929. PubMed ID: 31041874
[TBL] [Abstract][Full Text] [Related]
45. Opioids and Cancer Mortality.
Amaram-Davila J; Davis M; Reddy A
Curr Treat Options Oncol; 2020 Feb; 21(3):22. PubMed ID: 32095929
[TBL] [Abstract][Full Text] [Related]
46. Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.
Kroll SL; Nikolic E; Bieri F; Soyka M; Baumgartner MR; Quednow BB
Psychopharmacology (Berl); 2018 Dec; 235(12):3451-3464. PubMed ID: 30310961
[TBL] [Abstract][Full Text] [Related]
47. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
Corli O; Floriani I; Roberto A; Montanari M; Galli F; Greco MT; Caraceni A; Kaasa S; Dragani TA; Azzarello G; Luzzani M; Cavanna L; Bandieri E; Gamucci T; Lipari G; Di Gregorio R; Valenti D; Reale C; Pavesi L; Iorno V; Crispino C; Pacchioni M; Apolone G;
Ann Oncol; 2016 Jun; 27(6):1107-1115. PubMed ID: 26940689
[TBL] [Abstract][Full Text] [Related]
48. Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer.
Pu J; Wang N; Huang ZK; He XY; Yuan HB
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9393-9410. PubMed ID: 31773688
[TBL] [Abstract][Full Text] [Related]
49. The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care Cancer symptom study.
Boland JW; Allgar V; Boland EG; Bennett MI; Kaasa S; Hjermstad MJ; Johnson M
Eur J Clin Pharmacol; 2020 Mar; 76(3):393-402. PubMed ID: 31865411
[TBL] [Abstract][Full Text] [Related]
50. Controlled Release of Oxycodone as an Opioid Titration for Cancer Pain Relief: A Retrospective Study.
Zhao S; Xu C; Lin R
Med Sci Monit; 2020 Mar; 26():e920598. PubMed ID: 32225127
[TBL] [Abstract][Full Text] [Related]
51. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain.
Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E
J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675
[TBL] [Abstract][Full Text] [Related]
52. Effects of opioid medications on cognitive skills among Emergency Department patients.
Marco CA; Mann D; Rasp J; Ballester M; Perkins O; Holbrook MB; Rako K
Am J Emerg Med; 2018 Jun; 36(6):1009-1013. PubMed ID: 29137902
[TBL] [Abstract][Full Text] [Related]
53. Opioid Epidemic or Pain Crisis? Using the Virginia All Payer Claims Database to Describe Opioid Medication Prescribing Patterns and Potential Harms for Patients With Cancer.
LeBaron VT; Camacho F; Balkrishnan R; Yao NA; Gilson AM
J Oncol Pract; 2019 Dec; 15(12):e997-e1009. PubMed ID: 31682546
[TBL] [Abstract][Full Text] [Related]
54. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center.
Yennurajalingam S; Edwards T; Arthur JA; Lu Z; Najera J; Nguyen K; Manju J; Kuriakose L; Wu J; Liu D; Williams JL; Reddy SK; Bruera E
Cancer; 2018 Oct; 124(19):3942-3949. PubMed ID: 30192372
[TBL] [Abstract][Full Text] [Related]
55. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
[TBL] [Abstract][Full Text] [Related]
56. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
Yu Z; Wen L; Shen X; Zhang H
Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
[TBL] [Abstract][Full Text] [Related]
57. Effects of low-dose opioids on cognitive dysfunction.
McMorn S; Schoedel KA; Sellers EM
J Clin Oncol; 2011 Nov; 29(32):4342-3; author reply 4343-4. PubMed ID: 21969492
[No Abstract] [Full Text] [Related]
58. Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain.
Fladvad T; Klepstad P; Langaas M; Dale O; Kaasa S; Caraceni A; Skorpen F
Pharmacogenet Genomics; 2013 Mar; 23(3):117-26. PubMed ID: 23277092
[TBL] [Abstract][Full Text] [Related]
59. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
60. Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain.
Flory JH; Wiesenthal AC; Thaler HT; Koranteng L; Moryl N
J Pain Symptom Manage; 2016 Jan; 51(1):79-87.e1. PubMed ID: 26342726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
